Home » Healthcare » Pharmaceuticals » Pharmacovigilance Market

Pharmacovigilance Market By Service Type (In-House Pharmacovigilance Services, Outsourced Pharmacovigilance Services); By Pharmacovigilance Process Outsourcing (PvPO) Services (Case Processing, Signal Detection, Risk Management Services, Regulatory Affairs Outsourcing); By Type of Reporting (Pharmaceutical Companies, BioEnd-User Companies, Contract Research Organizations (CROs), Medical Device Companies, Academic Research Institutes); By Type of Reporting (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring); By Data Sources (Clinical Trials Data, Post-Marketing Surveillance DataPatient Support Programs, Social Media and Patient Forums, Medical Literature); By Pharmacovigilance Software (Adverse Event Reporting Software, Signal Detection Software, Risk Management Software, Integrated Software Solutions); By Type of Service Providers (BPO Companies, Contract Research Organizations (CROs, Pharmacovigilance Service Providers); By Pharmacovigilance Centers (National Pharmacovigilance Centers, Regional Pharmacovigilance Centers, Global Pharmacovigilance Centers); By Regulatory Reporting Requirements (FDA (U.S. Food and Drug Administration) Reporting, EMA (European Medicines Agency) Reporting, Other Regional Health Authorities); By Pharmacovigilance Audits and Inspections (Internal Audits, External Audits, Regulatory Inspections); By Quantum Dot Size (Narrow Band QDs, Broad Band QDs); By Region – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Price: $4999

Published: | Report ID: 9503 | Report Format : PDF
REPORT ATTRIBUTE DETAILS
Historical Period 2019-2022
Base Year 2023
Forecast Period 2024-2032
Pharmacovigilance Market Size 2023 USD 8615.2 Million
Pharmacovigilance Market, CAGR 8.90%
Pharmacovigilance Market Size 2032 USD 18557.3 Million

Market Insights

  • The global demand for Pharmacovigilance was valued at USD 8615.2 Million in 2023 and is expected to reach USD 18557.3 Million in 2032, growing at a CAGR of 8.90% between 2024 and 2032.
  • In 2022, the Outsourced Pharmacovigilance Services segment would lead the market.
  • In 2022, the signal detection segment dominated the market, accounting for more than 35.0% of total revenue. The case detection market is expected to grow at the fastest rate.
  • Pharmaceutical companies have the largest revenue share in 2022, while another key sector is Academic Research Institutes.
  • In 2022, the spontaneous reporting segment led the market, accounting for approximately 23.73%. The targeted spontaneous reporting sector is predicted to have the quickest CAGR.
  • The most in-demand segment is Post-Marketing Surveillance Data.
  • Patient Support Programs is the fastest growing area.
  • The most popular market sector is adverse event reporting software, while Signal Detection Software is another important market category.
  • Contract Research Organizations (CROs) dominate the Pharmacovigilance market, while Business Process Outsourcing (BPO) organizations are another rapidly rising area.
  • Global Pharmacovigilance Centres are in high demand in the market.
  • The FDA (Food and Drug Administration) and the EMA (European Medicines Agency) are becoming increasingly relevant in pharmacovigilance.
  • The market’s largest section is regulatory inspections, but external audits are also a substantial industry.
  • North America became the world’s largest pharmacovigilance market, accounting for 35.42% of total revenue in 2022, and Asia Pacific is expected to expand at a CAGR of roughly 8.5% through 2030.
  • Raising public awareness of safer drugs can increase market value.
  • Inconsistent reporting of adverse events in low and middle-income nations may impede market growth.

Pharmacovigilance Market

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Executive Summary

Market Definition

Pharmacovigilance is the process of monitoring and evaluating the safety and efficacy of pharmaceuticals. The pharmacovigilance market is the industry that offers services and solutions for collecting, analyzing, and reporting adverse drug reactions and other safety-related data. It is essential for maintaining pharmaceutical safety and protecting public health.

Market Overview

The global Pharmacovigilance Market has witnessed steady growth in recent years and is expected to grow at a CAGR of 8.90% between 2024 and 2032. The market was valued at USD 8615.2 million in 2023 and is expected to reach USD 18557.3 million in 2032.

The Pharmacovigilance market is a fast expanding segment of the healthcare industry. It focuses mostly on monitoring, analyzing, and preventing adverse effects and safety concerns associated with pharmaceutical goods. Pharmacovigilance ensures patient safety and regulatory compliance. With the increased usage of drugs and the complexity of drug research, there is a global demand for pharmacovigilance services.

Factors driving the market include an increased emphasis on patient safety, severe regulatory standards, and technological improvements. Pharmaceutical companies and regulatory organizations are emphasizing the necessity of monitoring and reporting adverse drug responses in order to maintain medication safety and efficacy. Furthermore, improvements in artificial intelligence, automation, and data analytics have increased the efficiency and effectiveness of pharmacovigilance.

Segmentation by Service Type

  • In 2022, the Outsourced Pharmacovigilance Services segment dominated the market, accounting for approximately 54.26%. Modern medical technology and affordability are mostly responsible for this. It is lucrative for a business to choose an outsourcing firm that can deliver and integrate all of these activities and skills, eliminating the burden of many contracts with third parties and leveraging process synergy within the same P.V. provider.
  • The in-house Pharmacovigilance Services category is predicted to grow considerably throughout the forecast period. In the coming years, this is expected to help the industry’s growth prospects.

Segmentation by Pharmacovigilance Process Outsourcing (PvPO) Services

  • In 2022, the signal detection segment dominated the market, accounting for more than 35.0% of total revenue. Signal identification is the process of detecting distinct safety signals and actively looking for them throughout registries and other healthcare data sources.
  • The case detection market is predicted to increase at the quickest rate, exceeding 7% in the projection years. This growth is due to the collection of adverse event data from a variety of sources, including spontaneous reports, clinical trials, post-marketing programs, and literature.

Segmentation by End-User

  • Pharmaceutical companies have the biggest revenue share in 2022. Because of expanded new product development activity in this industry, the pharmaceutical businesses segment is predicted to grow significantly in the next years. Drug development and usage have grown considerably in recent years.
  • Another major category is Academic Research Institutes

Segmentation by Type of Reporting

  • In 2022, the spontaneous reporting segment led the market, accounting for around 23.73%. It is because it employs a cost-effective and efficient approach of collecting data on potential ADRs.
  • The targeted spontaneous reporting segment is expected to have the fastest CAGR of 7.6% from 2023 to 2030. It focuses on a specific patient population and analyzes the hazards associated with specific treatment regimens, such as tuberculosis and HIV/AIDS.

Segmentation by Data Sources

  • The segment with the most demand is Post-Marketing Surveillance Data. It entails gathering and analyzing data on drug safety after the product has been approved and is available on the market.
  • The fastest expanding area is Patient Support Programs. These programs offer aid, knowledge, and resources to patients using drugs, guaranteeing their safety and well-being.

Segmentation by Pharmacovigilance Software

  • The most popular market sector is adverse event reporting software. This program is used to record, manage, and report adverse events associated with drugs or medical equipment. It is critical for pharmacovigilance since it ensures that adverse events are reported and analysed on time.
  • Signal Detection Software is another key market category. This software assists in detecting potential signals or patterns that may suggest previously unknown dangers related with drugs or medical devices.

Segmentation by Type of Service Providers

  • Contract Research Organizations (CROs) dominate the Pharmacovigilance market. CROs offer a variety of services, including clinical trial management and data analysis, which are critical to guaranteeing drug safety.
  • Business Process Outsourcing (BPO) companies are another fast-growing segment. These companies provide pharmaceutical corporations with specific pharmacovigilance services such as adverse event reporting and signal detection.

Segmentation by Pharmacovigilance Centers

  • Global Pharmacovigilance Centres are in high demand in the market. These centres serve a critical role in international pharmacovigilance coordination and harmonization. They allow information exchange and collaboration between governments and regions.
  • While National and Regional Pharmacovigilance Centres are equally significant.

Segmentation by Regulatory Reporting Requirements

  • the FDA (Food and Drug Administration) and the EMA (European Medicines Agency), these authorities are gaining relevance in pharmacovigilance.

Segmentation by Pharmacovigilance Audits and Inspections

  • The market’s dominant segment is regulatory inspections. Regulatory bodies perform these inspections to ensure compliance with pharmacovigilance legislation and standards. They play an important role in ensuring that pharmaceutical companies and other stakeholders follow safety standards and regulatory obligations.
  • External audits are also a significant sector. These audits are undertaken by independent organizations or authorities to assess pharmacovigilance methods and procedures.

Segmentation by Region

  • North America emerged as the world’s largest pharmacovigilance market, accounting for 35.42% of total revenue in 2022
  • Asia Pacific is projected to increase at a CAGR of around 8.5% through 2030.
  • The rest of the world, including Latin America, the Middle East, and Africa, supplies the remaining demand for Pharmacovigilance.

Pharmacovigilance Market Research

North America emerged as the world’s largest pharmacovigilance market. The presence of prominent market players is a critical component in driving market revenue growth. The growth of pharmacovigilance efforts in a number of countries in this region is also contributing to the increased market revenue. Significant investments in drug research have also contributed significantly to the region’s market revenue growth. Because of the number of qualified healthcare experts in the United States, the market generated the most income. In addition, major market players in this country are developing new goods and collaborating to strengthen their market position.

The market is further driven by the strong presence of prominent market players engaged in strategic initiatives such as new product launches and mergers and acquisitions. Asia-Pacific is expected to expand at the quickest CAGR of 8.5% during the projection period. This expansion is fueled mostly by the region’s burgeoning generic medicine sector. Factors such as rising ADR cases, increased public safety awareness, and stringent government regulations are expected to drive market growth in the area.

Key Highlights of the Report

The global Pharmacovigilance Market is segmented by Service Type, Pharmacovigilance Process Outsourcing (PvPO) Services, End-Users, Type of Reporting, Data Sources, Pharmacovigilance Software, Type of Service Providers, Pharmacovigilance Centers, Regulatory Reporting Requirements, Pharmacovigilance Audits and Inspections,  and region. In 2022, the spontaneous reporting category led the market, with pharmaceutical businesses having the largest revenue share. additionally, the fastest growing field is Patient Support Programs, while the most popular market sector is adverse event reporting software. Also, the FDA (Food and Drug Administration) and the EMA (European Medicines Agency) are becoming increasingly relevant in pharmacovigilance, with North America leading the market growth.

The market’s primary drivers are an increased emphasis on patient safety and regulatory compliance, rising demand for pharmacovigilance services, and technological advancements. Furthermore, high installation and maintenance costs, stringent regulatory requirements, complex reporting frameworks, and limited awareness and knowledge are the significant limitations of the industry.

Nonetheless, North America has emerged as the world’s largest pharmacovigilance market. The presence of major market competitors is crucial for driving market revenue growth. Furthermore, Asia-Pacific is estimated to grow at the fastest CAGR of 8.5% throughout the projected period.

What Are The Main Drivers Of The Global Pharmacovigilance Market?

One of the primary drivers of the Pharmacovigilance industry is the growing emphasis on patient safety and regulatory compliance. With increased concern about drug safety, pharmaceutical businesses and regulatory agencies are focusing more on monitoring and assessing the safety of pharmaceutical goods. This has increased the demand for pharmacovigilance services, which collect, evaluate, and report adverse drug reactions and other safety-related data. Furthermore, technological breakthroughs such as artificial intelligence and automation have considerably improved pharmacovigilance operations, increasing their efficiency and effectiveness.

What Are The Major Challenges Faced By The Global Pharmacovigilance Market?

While the Pharmacovigilance market has significant growth possibilities, there are several constraints that must be addressed. One of the biggest barriers is the high expense of implementing and maintaining pharmacovigilance systems. Creating and maintaining a strong pharmacovigilance infrastructure necessitates significant investments in End-User, competent personnel, and compliance with regulations. Furthermore, severe regulatory requirements and complex reporting frameworks present problems for pharmaceutical businesses and service providers in assuring compliance and timely reporting.

What Are The Growth Opportunities In The Global Pharmacovigilance Market?

The pharmacovigilance market offers numerous potential for expansion and development. The global expansion of the pharmaceutical and bioEnd-User sectors has created an increased demand for pharmacovigilance services to ensure medication safety and efficacy. Furthermore, the combination of real-world data and advanced analytics has the potential to transform pharmacovigilance methods by allowing for more complete and proactive monitoring of medication safety. Collaboration among regulatory authorities, healthcare providers, and pharmaceutical corporations offers potential to improve pharmacovigilance procedures by sharing knowledge, resources, and experience.

Market Drivers

The global Pharmacovigilance Market is driven by several factors. The following are the key drivers of the global Pharmacovigilance Market:

Raising Public Awareness Of Safer Medicines

Safety and efficacy are the two most critical factors that a medicine must meet during each clinical trial phase. The populace is becoming more aware of the side effects of over-the-counter pharmaceuticals, increasing demand for safer medications. This aspect is expected to drive market growth due to the monitoring of marketed drugs for potential ADRs. Furthermore, government activities and programs, as well as pharmaceutical firms’ awareness campaigns, have a bigger impact on distributing credible information about drugs, proper use, adverse effects, and other topics.

For instance, in March 2021, the American Society of Pharmacovigilance officially launched a national awareness campaign to encourage victims of adverse drug events to share their stories and build community support, while applauding healthcare professionals and organizations for discussing how they can help with medication safety.

As a result, such encouraging measures are projected to drive pharmacovigilance market growth over the forecast period.

Market Restraints

The global Pharmacovigilance Market faces some challenges that may hinder its growth. These include the following:

Inconsistent Reporting Of Adverse Events In Low And Middle-Income Countries

Inconsistent reporting occurs as a result of a lack of patient knowledge of adverse occurrences. In the event of an adverse event, the patient becomes anxious and reports all of their symptoms as AE. However, not all reported adverse events are substantial, causing pharmaceutical company committees to make wrong conclusions, resulting in the drug’s withdrawal. In low- and middle-income nations, specialty services lack suitable skills and services/software. Furthermore, governments and pharmaceutical corporations are making fewer efforts to raise awareness about adverse event reporting.

These issues are expected to slow market growth in low- and middle-income nations.

Opportunities

The global Pharmacovigilance Market offers significant growth opportunities. These include the following:

Outsourcing PV Services

Today’s market permits pharmaceutical businesses and hospitals to outsource PV services. Outsourcing provides various advantages to manufacturing organizations in terms of time limitations and amenities that an outsourced service may supply.

Outsourcing also enables businesses to customize their processes to meet their specific needs, which speeds up the evaluation process.

The market is experiencing an increase in demand for these services, creating numerous prospects for outsourcing service providers. These companies are working to expand their service offerings in order to deliver more complex solutions to their clientele. For instance, on International Patient Safety Day 2019, Bayer launched the SafeTrack digital tool to record adverse occurrences. The program is a simple and convenient web platform that permits immediate reporting of an AE.

Competitive Landscape

Pharmacovigilance Market Report

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key Players

The global Pharmacovigilance Market is highly competitive, with several key players. Some of the major players in the market and their market share are as follows:

  • Accenture
  • IQVIA
  • Cognizant
  • Clinquest Group B.V. (Linical Americas)
  • IBM Corp.
  • Laboratory Corporation of America Holdings
  • ArisGlobal
  • Capgemini
  • ITClinical
  • ICON plc.
  • TAKE Solutions Ltd.
  • Parexel International Corporation.
  • Wipro Ltd.
  • United BioSource LLC
  • BioClinica Inc.
  • ClinChoice (formerly FMD K&L)

These organizations prioritize product innovation, Pharmacovigilance Centers expansion, and mergers and acquisitions to stay competitive.

The global Pharmacovigilance Market’s key players continually seek to stay ahead by offering new products and developments.

In June 2021, SSI Strategy, LLC has announced the acquisition of Fiore Healthcare Advisors, LLC. This purchase intends to strengthen SSI’s existing robust Clinical Research and Drug Safety offerings by bringing on a team of seasoned Safety Physicians and Clinical Research support.

In April 2021, ResoluteAI, the science research platform, has announced the availability of a collection of tools to help with post-market surveillance and PV analysis.

In September 2022, Veeva Systems has developed two new Veeva Crossix products to improve multichannel marketing.

Summary of Key Findings

  • Outsourcing PV Services to Drive Market Growth.
  • Market segmented by Service Type, Pharmacovigilance Process Outsourcing (PvPO) Services, End-Users, Type of Reporting, Data Sources, Pharmacovigilance Software, Type of Service Providers, Regulatory Reporting Requirements, Pharmacovigilance Audits and Inspections, and region.
  • In 2022, the Outsourced Pharmacovigilance Services segment dominated the market.
  • In 2022, pharmaceutical businesses will have the largest revenue share
  • North America is leading market growth; the market is highly competitive with key players including Accenture; IQVIA; Cognizant; Clinquest Group B.V. (Linical Americas); IBM Corp and Others.

Future Outlook

  • Increasing focus on drug safety and regulatory compliance
  • Growing adoption of End-User and automation in pharmacovigilance processes
  • Rising demand for personalized medicine and biopharmaceuticals
  • Expansion of pharmaceutical and bioEnd-User industries globally
  • Increasing number of adverse drug reactions and safety concerns
  • Emerging markets presenting growth opportunities
  • Integration of artificial intelligence and machine learning in pharmacovigilance
  • Collaboration between regulatory authorities and industry stakeholders

How CXOs Can Benefit from the Credence Research Pharmacovigilance Market Report

The Credence Research Pharmacovigilance Market Report provides CXOs with a comprehensive overview of the market, including:

  • Market size and growth forecast: The report provides detailed estimates of the global Pharmacovigilance Market size, segmented by Service Type, Pharmacovigilance Process Outsourcing (PvPO) Services, End-Users, Type of Reporting, Data Sources, Pharmacovigilance Software, Type of Service Providers, Regulatory Reporting Requirements, Pharmacovigilance Audits and Inspections, and region. It also includes forecasts for the market through 2032, based on key trends and drivers.
  • Market segmentation: The report segments the Pharmacovigilance Market by Service Type, Pharmacovigilance Process Outsourcing (PvPO) Services, End-Users, Type of Reporting, Data Sources, Pharmacovigilance Software, Type of Service Providers, Regulatory Reporting Requirements, Pharmacovigilance Audits and Inspections, and region. This segmentation provides CXOs with a granular understanding of the market and the opportunities in each segment.
  • Competitive landscape: The report profiles the key players in the Pharmacovigilance Market and provides insights into their strategies, product offerings, and financial performance. This information can help CXOs to identify and assess their competition.
  • Key trends and drivers: The report identifies and analyzes the key trends and drivers that are shaping the Pharmacovigilance Market. This information can help CXOs to make informed decisions about their investments and strategies.

CXOs can use the insights from the Credence Research Pharmacovigilance Market Report to:

  • Identify growth opportunities: The report can help CXOs to identify new growth opportunities in the Pharmacovigilance Market. For example, this report provides valuable insights and analysis on market trends, competitive landscape, and emerging technologies.
  • Make informed investment decisions: The report can help CXOs to make informed investment decisions about Pharmacovigilance. For example, it provides insights into market trends, growth potential, and regulatory landscape, which can guide CXOs in identifying investment opportunities and assessing the risks involved.
  • Develop competitive strategies: The report can help CXOs to develop competitive strategies for their Pharmacovigilance businesses. For example, it provides insights into market trends, emerging technologies, and competitive landscape. With this information, CXOs can identify key areas for differentiation, understand customer needs, and develop strategies to stay ahead of the competition.
  • Track market developments: The report can help CXOs to track market developments and stay ahead of the curve. For example, the report provides insights into the latest trends and innovations in the Pharmacovigilance Market.

Overall, the Credence Research Pharmacovigilance Market Report is a valuable resource for CXOs who are looking to gain a deeper understanding of the market and identify opportunities for growth.

Segmentation

By Service Type:

  • In-House Pharmacovigilance Services
  • Outsourced Pharmacovigilance Services

By Pharmacovigilance Process Outsourcing (PvPO) Services:

  • Case Processing
  • Signal Detection
  • Risk Management Services
  • Regulatory Affairs Outsourcing

By Type of Reporting:

  • Pharmaceutical Companies
  • BioEnd-User Companies
  • Contract Research Organizations (CROs)
  • Medical Device Companies
  • Academic Research Institutes

By Type of Reporting:

  • Spontaneous Reporting
  • Intensified ADR Reporting
  • Targeted Spontaneous Reporting
  • Cohort Event Monitoring

By Data Sources:

  • Clinical Trials Data
  • Post-Marketing Surveillance Data
  • Patient Support Programs
  • Social Media and Patient Forums
  • Medical Literature

By Pharmacovigilance Software:

  • Adverse Event Reporting Software
  • Signal Detection Software
  • Risk Management Software
  • Integrated Software Solutions

By Type of Service Providers:

  • Business Process Outsourcing (BPO) Companies
  • Contract Research Organizations (CROs)
  • Pharmacovigilance Service Providers

 By Pharmacovigilance Centers:

  • National Pharmacovigilance Centers
  • Regional Pharmacovigilance Centers
  • Global Pharmacovigilance Centers

By Regulatory Reporting Requirements:

  • FDA (U.S. Food and Drug Administration) Reporting
  • EMA (European Medicines Agency) Reporting
  • Other Regional Health Authorities

By Pharmacovigilance Audits and Inspections:

  • Internal Audits
  • External Audits
  • Regulatory Inspections
  • By Region
    • North America
      • The U.S.
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • The U.K.
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • South-east Asia
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Argentina
      • Rest of Latin America
    • Middle East & Africa
      • GCC Countries
      • South Africa
      • Rest of Middle East and Africa
Table of Content
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Market Introduction
2. Executive Summary
2.1. Market Snapshot: Global  Pharmacovigilance Market
2.1.1. Global  Pharmacovigilance Market, By Service Type
2.1.2. Global  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services
2.1.3. Global  Pharmacovigilance Market, By End-User
2.1.4. Global  Pharmacovigilance Market, By Type of Reporting
2.1.5. Global  Pharmacovigilance Market, By Data Sources
2.1.6. Global  Pharmacovigilance Market, By  Pharmacovigilance Software
2.1.7. Global  Pharmacovigilance Market, By Type of Service Providers
2.1.8. Global  Pharmacovigilance Market, By  Pharmacovigilance Center
2.1.9. Global  Pharmacovigilance Market, By Regulatory Reporting Requirements
2.1.10. Global  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections
2.1.11. Global  Pharmacovigilance Market, By Region
2.2. Insights from Primary Respondents
3. Market Dynamics & Factors Analysis
3.1. Introduction
3.1.1. Global  Pharmacovigilance Market Value, 2017-2030, (US$ Mn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Pharmacovigilance Market Drivers
3.2.2. Pharmacovigilance Market Restraints
3.2.3. Pharmacovigilance Market Opportunities
3.2.4. Major  Pharmacovigilance Market Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Service Type
3.5.2. Pharmacovigilance Process Outsourcing (PvPO) Services
3.5.3. End-User
3.5.4. Type of Reporting
3.5.5. Data Sources
3.5.6. Pharmacovigilance Software
3.5.7. Type of Service Providers
3.5.8. Pharmacovigilance Center
3.5.9. Regulatory Reporting Requirements
3.5.10. Pharmacovigilance Audits and Inspections
3.5.11. Geography
4. Market Competitive Landscape Analysis
4.1. Company Market Share Analysis, 2022
4.1.1. Global  Pharmacovigilance Market: Company Market Share, Value 2022
4.1.2. Global  Pharmacovigilance Market: Top 6 Company Market Share, Value 2022
4.1.3. Global  Pharmacovigilance Market: Top 3 Company Market Share, Value 2022
4.2. Global  Pharmacovigilance Market: Company Revenue Share Analysis, 2022
4.3. Company Assessment Metrics, 2022
4.3.1. Stars
4.3.2. Emerging Leaders
4.3.3. Pervasive Players
4.3.4. Participants
4.4. Startups/ SMEs Assessment Metrics, 2022
4.4.1. Progressive Companies
4.4.2. Responsive Companies
4.4.3. Dynamic Companies
4.4.4. Starting Blocks
4.5. Strategic Development
4.5.1. Acquisition and Mergers
4.5.2. New Type Launch
4.5.3. Regional Expansion
4.5.4. Partnerships
4.6. Key Player Type Matrix
4.7. Potential for New Players in the Global  Pharmacovigilance Market
5. Premium Insights
5.1. STAR (Situation, Task, Action, Results) Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Bargaining Power of Buyers/Consumers
5.2.3. Bargaining Power of Suppliers
5.2.4. Threat of Substitute Types
5.2.5. Intensity of Competitive Rivalry
5.3. PESTEL Analysis
5.3.1. Political Factors
5.3.2. Economic Factors
5.3.3. Social Factors
5.3.4. Technological Factors
5.3.5. Environmental Factors
5.3.6. Legal Factors
5.4. Key Market Trends
5.4.1. Demand Side Trends
5.4.2. Supply Side Trends
5.5. Value Chain Analysis
5.6. Technology Analysis
5.6.1. Plasma Protein Binding Studies in the global market
5.6.2. Patent Analysis
5.6.3. Emerging technologies and their potential disruption to the market
5.7. Consumer Behaviour Analysis
5.7.1. Consumer Preferences and Expectations
5.7.2. Factors Influencing Consumer Buying Decisions
5.7.2.1. North America
5.7.2.2. Europe
5.7.2.3. Asia Pacific
5.7.2.4. Latin America
5.7.2.5. Middle East and Africa
5.7.3. Consumer Pain Points
5.8. Analysis and Recommendations
5.9. Adjacent Market Analysis
6. Market Positioning of Key Players, 2022
6.1. Company market share of key players, 2022
6.2. Competitive Benchmarking
6.3. Market Positioning of Key Vendors
6.4. Geographical Presence Analysis
6.5. Major Strategies Adopted by Key Players
6.5.1. Key Strategies Analysis
6.5.2. Mergers and Acquisitions
6.5.3. Partnerships
6.5.4. Type Launch
6.5.5. Geographical Expansion
6.5.6. Autoimmune Diseases
7. Impact Analysis of COVID 19 and Russia – Ukraine War on  Pharmacovigilance Market
7.1. Ukraine-Russia War Impact
7.1.1. Uncertainty and Economic Instability
7.1.2. Supply chain disruptions
7.1.3. Regional market shifts
7.1.4. Shift in government priorities
7.2. COVID-19 Impact Analysis
7.2.1. Supply Chain Disruptions
7.2.2. Demand Fluctuations
7.2.3. Shift in Type Mix
7.2.4. Reduced Plasma Protein Binding Studies Activity
7.2.5. Regional Impact Analysis
7.2.5.1. North America
7.2.5.2. Europe
7.2.5.3. Asia Pacific
7.2.5.4. Latin America
7.2.5.5. Middle East and Africa
8. Global  Pharmacovigilance Market, By Service Type
8.1. Global  Pharmacovigilance Market Overview, By Service Type
8.1.1. Global  Pharmacovigilance Market Revenue Share, By Service Type, 2022 Vs 2030 (in %)
8.2. In-House  Pharmacovigilance Services
8.2.1. Global  Pharmacovigilance Market, By IN-HOUSE  Pharmacovigilance SERVICES, By Region, 2017-2030 (US$ Mn)
8.2.2. Market Dynamics for IN-HOUSE  Pharmacovigilance SERVICES
8.2.2.1. Drivers
8.2.2.2. Restraints
8.2.2.3. Opportunities
8.2.2.4. Trends
8.3. Outsourced  Pharmacovigilance Services
8.3.1. Global  Pharmacovigilance Market, By Outsourced  Pharmacovigilance Services, By Region, 2017-2030 (US$ Mn)
8.3.2. Market Dynamics for Outsourced  Pharmacovigilance Services
8.3.2.1. Drivers
8.3.2.2. Restraints
8.3.2.3. Opportunities
8.3.2.4. Trends
9. Global  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services
9.1. Global  Pharmacovigilance Market Overview, By  Pharmacovigilance Process Outsourcing (PvPO) Services
9.1.1. Global  Pharmacovigilance Market Revenue Share, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2022 Vs 2030 (in %)
9.2. Case Processing
9.2.1. Global  Pharmacovigilance Market, By Case Processing, By Region, 2017-2030 (US$ Mn)
9.2.2. Market Dynamics for Case Processing
9.2.2.1. Drivers
9.2.2.2. Restraints
9.2.2.3. Opportunities
9.2.2.4. Trends
9.3. Signal Detection
9.3.1. Global  Pharmacovigilance Market, By Signal Detection, By Region, 2017-2030 (US$ Mn)
9.3.2. Market Dynamics for Signal Detection
9.3.2.1. Drivers
9.3.2.2. Restraints
9.3.2.3. Opportunities
9.3.2.4. Trends
9.4. Risk Management Services
9.4.1. Global  Pharmacovigilance Market, By Risk Management Services, By Region, 2017-2030 (US$ Mn)
9.4.2. Market Dynamics for Risk Management Services
9.4.2.1. Drivers
9.4.2.2. Restraints
9.4.2.3. Opportunities
9.4.2.4. Trends
9.5. Regulatory Affairs Outsourcing
9.5.1. Global  Pharmacovigilance Market, By Regulatory Affairs Outsourcing, By Region, 2017-2030 (US$ Mn)
9.5.2. Market Dynamics for Regulatory Affairs Outsourcing
9.5.2.1. Drivers
9.5.2.2. Restraints
9.5.2.3. Opportunities
9.5.2.4. Trends
10. Global  Pharmacovigilance Market, By End-User
10.1. Global  Pharmacovigilance Market Overview, By End-User
10.1.1. Global  Pharmacovigilance Market Revenue Share, By End-User, 2022 Vs 2030 (in %)
10.2. Pharmaceutical Companies
10.2.1. Global  Pharmacovigilance Market, By Pharmaceutical Companies, By Region, 2017-2030 (US$ Mn)
10.2.2. Market Dynamics for Pharmaceutical Companies
10.2.2.1. Drivers
10.2.2.2. Restraints
10.2.2.3. Opportunities
10.2.2.4. Trends
10.3. Biotechnology Companies
10.3.1. Global  Pharmacovigilance Market, By Biotechnology Companies, By Region, 2017-2030 (US$ Mn)
10.3.2. Market Dynamics for Biotechnology Companies
10.3.2.1. Drivers
10.3.2.2. Restraints
10.3.2.3. Opportunities
10.3.2.4. Trends
10.4. Contract Research Organizations (CROs)
10.4.1. Global  Pharmacovigilance Market, By Contract Research Organizations (CROs), By Region, 2017-2030 (US$ Mn)
10.4.2. Market Dynamics for Contract Research Organizations (CROs)
10.4.2.1. Drivers
10.4.2.2. Restraints
10.4.2.3. Opportunities
10.4.2.4. Trends
10.5. Medical Device Companies
10.5.1. Global  Pharmacovigilance Market, By Medical Device Companies, By Region, 2017-2030 (US$ Mn)
10.5.2. Market Dynamics for Medical Device Companies
10.5.2.1. Drivers
10.5.2.2. Restraints
10.5.2.3. Opportunities
10.5.2.4. Trends
10.6. Academic Research Institutes
10.6.1. Global  Pharmacovigilance Market, By Academic Research Institutes, By Region, 2017-2030 (US$ Mn)
10.6.2. Market Dynamics for Academic Research Institutes
10.6.2.1. Drivers
10.6.2.2. Restraints
10.6.2.3. Opportunities
10.6.2.4. Trends
11. Global  Pharmacovigilance Market, By Type of Reporting
11.1. Global  Pharmacovigilance Market Overview, by Type of Reporting
11.1.1. Global  Pharmacovigilance Market Revenue Share, By Type of Reporting, 2022 Vs 2030 (in %)
11.2. Spontaneous Reporting
11.2.1. Global  Pharmacovigilance Market, By Spontaneous Reporting, By Region, 2017-2030 (US$ Mn)
11.2.2. Market Dynamics for Spontaneous Reporting
11.2.2.1. Drivers
11.2.2.2. Restraints
11.2.2.3. Opportunities
11.2.2.4. Trends
11.3. Intensified ADR Reporting
11.3.1. Global  Pharmacovigilance Market, By Intensified ADR Reporting, By Region, 2017-2030 (US$ Mn)
11.3.2. Market Dynamics for Intensified ADR Reporting
11.3.2.1. Drivers
11.3.2.2. Restraints
11.3.2.3. Opportunities
11.3.2.4. Trends
11.4. Targeted Spontaneous Reporting
11.4.1. Global  Pharmacovigilance Market, By Targeted Spontaneous Reporting, By Region, 2017-2030 (US$ Mn)
11.4.2. Market Dynamics for Targeted Spontaneous Reporting
11.4.2.1. Drivers
11.4.2.2. Restraints
11.4.2.3. Opportunities
11.4.2.4. Trends
11.5. Cohort Event Monitoring
11.5.1. Global  Pharmacovigilance Market, By Cohort Event Monitoring, By Region, 2017-2030 (US$ Mn)
11.5.2. Market Dynamics for Cohort Event Monitoring
11.5.2.1. Drivers
11.5.2.2. Restraints
11.5.2.3. Opportunities
11.5.2.4. Trends
12. Global  Pharmacovigilance Market, By Data Sources
12.1. Global  Pharmacovigilance Market Overview, By Data Sources
12.1.1. Global  Pharmacovigilance Market Revenue Share, By Data Sources, 2022 Vs 2030 (in %)
12.2. Clinical Trials Data
12.2.1. Global  Pharmacovigilance Market, By Clinical Trials Data, By Region, 2017-2030 (US$ Mn)
12.2.2. Market Dynamics for Clinical Trials Data
12.2.2.1. Drivers
12.2.2.2. Restraints
12.2.2.3. Opportunities
12.2.2.4. Trends
12.3. Post-Marketing Surveillance Data
12.3.1. Global  Pharmacovigilance Market, By Post-Marketing Surveillance Data, By Region, 2017-2030 (US$ Mn)
12.3.2. Market Dynamics for Post-Marketing Surveillance Data
12.3.2.1. Drivers
12.3.2.2. Restraints
12.3.2.3. Opportunities
12.3.2.4. Trends
12.4. Patient Support Programs
12.4.1. Global  Pharmacovigilance Market, By Patient Support Programs, By Region, 2017-2030 (US$ Mn)
12.4.2. Market Dynamics for Patient Support Programs
12.4.2.1. Drivers
12.4.2.2. Restraints
12.4.2.3. Opportunities
12.4.2.4. Trends
12.5. Social Media and Patient Forums
12.5.1. Global  Pharmacovigilance Market, By Social Media and Patient Forums, By Region, 2017-2030 (US$ Mn)
12.5.2. Market Dynamics for Social Media and Patient Forums
12.5.2.1. Drivers
12.5.2.2. Restraints
12.5.2.3. Opportunities
12.5.2.4. Trends
12.6. Medical Literature
12.6.1. Global  Pharmacovigilance Market, By Medical Literature, By Region, 2017-2030 (US$ Mn)
12.6.2. Market Dynamics for Medical Literature
12.6.2.1. Drivers
12.6.2.2. Restraints
12.6.2.3. Opportunities
12.6.2.4. Trends
13. Global  Pharmacovigilance Market, By  Pharmacovigilance Software
13.1. Global  Pharmacovigilance Market Overview, By  Pharmacovigilance Software
13.1.1. Global  Pharmacovigilance Market Revenue Share, By  Pharmacovigilance Software, 2022 Vs 2030 (in %)
13.2. Adverse Event Reporting Software
13.2.1. Global  Pharmacovigilance Market, By Adverse Event Reporting Software, By Region, 2017-2030 (US$ Mn)
13.2.2. Market Dynamics for Adverse Event Reporting Software
13.2.2.1. Drivers
13.2.2.2. Restraints
13.2.2.3. Opportunities
13.2.2.4. Trends
13.3. Signal Detection Software
13.3.1. Global  Pharmacovigilance Market, By Signal Detection Software, By Region, 2017-2030 (US$ Mn)
13.3.2. Market Dynamics for Signal Detection Software
13.3.2.1. Drivers
13.3.2.2. Restraints
13.3.2.3. Opportunities
13.3.2.4. Trends
13.4. Risk Management Software
13.4.1. Global  Pharmacovigilance Market, By Risk Management Software, By Region, 2017-2030 (US$ Mn)
13.4.2. Market Dynamics for Risk Management Software
13.4.2.1. Drivers
13.4.2.2. Restraints
13.4.2.3. Opportunities
13.4.2.4. Trends
13.5. Integrated Software Solutions
13.5.1. Global  Pharmacovigilance Market, By Integrated Software Solutions, By Region, 2017-2030 (US$ Mn)
13.5.2. Market Dynamics for Integrated Software Solutions
13.5.2.1. Drivers
13.5.2.2. Restraints
13.5.2.3. Opportunities
13.5.2.4. Trends
14. Global  Pharmacovigilance Market, By Type of Service Providers
14.1. Global  Pharmacovigilance Market Overview, By Type of Service Providers
14.1.1. Global  Pharmacovigilance Market Revenue Share, By Type of Service Providers, 2022 Vs 2030 (in %)
14.2. Business Process Outsourcing (BPO) Companies
14.2.1. Global  Pharmacovigilance Market, By Business Process Outsourcing (BPO) Companies, By Region, 2017-2030 (US$ Mn)
14.2.2. Market Dynamics for Business Process Outsourcing (BPO) Companies
14.2.2.1. Drivers
14.2.2.2. Restraints
14.2.2.3. Opportunities
14.2.2.4. Trends
14.3. Contract Research Organizations (CROs)
14.3.1. Global  Pharmacovigilance Market, By Contract Research Organizations (CROs), By Region, 2017-2030 (US$ Mn)
14.3.2. Market Dynamics for Contract Research Organizations (CROs)
14.3.2.1. Drivers
14.3.2.2. Restraints
14.3.2.3. Opportunities
14.3.2.4. Trends
14.4. Pharmacovigilance Service Providers
14.4.1. Global  Pharmacovigilance Market, By  Pharmacovigilance Service Providers, By Region, 2017-2030 (US$ Mn)
14.4.2. Market Dynamics for  Pharmacovigilance Service Providers
14.4.2.1. Drivers
14.4.2.2. Restraints
14.4.2.3. Opportunities
14.4.2.4. Trends
15. Global  Pharmacovigilance Market, By  Pharmacovigilance Center
15.1. Global  Pharmacovigilance Market Overview, By  Pharmacovigilance Center
15.1.1. Global  Pharmacovigilance Market Revenue Share, By  Pharmacovigilance Center, 2022 Vs 2030 (in %)
15.2. National  Pharmacovigilance Centers
15.2.1. Global  Pharmacovigilance Market, By National  Pharmacovigilance Centers, By Region, 2017-2030 (US$ Mn)
15.2.2. Market Dynamics for National  Pharmacovigilance Centers
15.2.2.1. Drivers
15.2.2.2. Restraints
15.2.2.3. Opportunities
15.2.2.4. Trends
15.3. Regional  Pharmacovigilance Centers
15.3.1. Global  Pharmacovigilance Market, By Regional  Pharmacovigilance Centers, By Region, 2017-2030 (US$ Mn)
15.3.2. Market Dynamics for Regional  Pharmacovigilance Centers
15.3.2.1. Drivers
15.3.2.2. Restraints
15.3.2.3. Opportunities
15.3.2.4. Trends
15.4. Global  Pharmacovigilance Centers
15.4.1. Global  Pharmacovigilance Market, By Global  Pharmacovigilance Centers, By Region, 2017-2030 (US$ Mn)
15.4.2. Market Dynamics for Global  Pharmacovigilance Centers
15.4.2.1. Drivers
15.4.2.2. Restraints
15.4.2.3. Opportunities
15.4.2.4. Trends
16. Global  Pharmacovigilance Market, By Regulatory Reporting Requirements
16.1. Global  Pharmacovigilance Market Overview, By Regulatory Reporting Requirements
16.1.1. Global  Pharmacovigilance Market Revenue Share, By Regulatory Reporting Requirements, 2022 Vs 2030 (in %)
16.2. FDA (U.S. Food and Drug Administration) Reporting
16.2.1. Global  Pharmacovigilance Market, By FDA (U.S. Food and Drug Administration) Reporting, By Region, 2017-2030 (US$ Mn)
16.2.2. Market Dynamics for FDA (U.S. Food and Drug Administration) Reporting
16.2.2.1. Drivers
16.2.2.2. Restraints
16.2.2.3. Opportunities
16.2.2.4. Trends
16.3. EMA (European Medicines Agency) Reporting
16.3.1. Global  Pharmacovigilance Market, By EMA (European Medicines Agency) Reporting, By Region, 2017-2030 (US$ Mn)
16.3.2. Market Dynamics for EMA (European Medicines Agency) Reporting
16.3.2.1. Drivers
16.3.2.2. Restraints
16.3.2.3. Opportunities
16.3.2.4. Trends
16.4. Other Regional Health Authorities
16.4.1. Global  Pharmacovigilance Market, By Other Regional Health Authorities, By Region, 2017-2030 (US$ Mn)
16.4.2. Market Dynamics for Other Regional Health Authorities
16.4.2.1. Drivers
16.4.2.2. Restraints
16.4.2.3. Opportunities
16.4.2.4. Trends
17. Global  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections
17.1. Global  Pharmacovigilance Market Overview, By  Pharmacovigilance Audits and Inspections
17.1.1. Global  Pharmacovigilance Market Revenue Share, By  Pharmacovigilance Audits and Inspections, 2022 Vs 2030 (in %)
17.2. Internal Audits
17.2.1. Global  Pharmacovigilance Market, By Internal Audits, By Region, 2017-2030 (US$ Mn)
17.2.2. Market Dynamics for Internal Audits
17.2.2.1. Drivers
17.2.2.2. Restraints
17.2.2.3. Opportunities
17.2.2.4. Trends
17.3. External Audits
17.3.1. Global  Pharmacovigilance Market, By External Audits, By Region, 2017-2030 (US$ Mn)
17.3.2. Market Dynamics for External Audits
17.3.2.1. Drivers
17.3.2.2. Restraints
17.3.2.3. Opportunities
17.3.2.4. Trends
17.4. Regulatory Inspections
17.4.1. Global  Pharmacovigilance Market, By Regulatory Inspections, By Region, 2017-2030 (US$ Mn)
17.4.2. Market Dynamics for Regulatory Inspections
17.4.2.1. Drivers
17.4.2.2. Restraints
17.4.2.3. Opportunities
17.4.2.4. Trends
18. Global  Pharmacovigilance Market, By Region
18.1. Global  Pharmacovigilance Market Overview, by Region
18.1.1. Global  Pharmacovigilance Market, By Region, 2022 vs 2030 (in%)
18.2. Service Type
18.2.1. Global  Pharmacovigilance Market, By Service Type, 2017-2030 (US$ Mn)
18.3. Pharmacovigilance Process Outsourcing (PvPO) Services
18.3.1. Global  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030 (US$ Mn)
18.4. End-User
18.4.1. Global  Pharmacovigilance Market, By End-User, 2017-2030 (US$ Mn)
18.5. Type of Reporting
18.5.1. Global  Pharmacovigilance Market, By Type of Reporting, 2017-2030 (US$ Mn)
18.6. Data Sources
18.6.1. Global  Pharmacovigilance Market, By Data Sources, 2017-2030 (US$ Mn)
18.7. Pharmacovigilance Software
18.7.1. Global  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030 (US$ Mn)
18.8. Type of Service Providers
18.8.1. Global  Pharmacovigilance Market, By Type of Service Providers, 2017-2030 (US$ Mn)
18.9. Pharmacovigilance Center
18.9.1. Global  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030 (US$ Mn)
18.10. Regulatory Reporting Requirements
18.10.1. Global  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030 (US$ Mn)
18.11. Pharmacovigilance Audits and Inspections
18.11.1. Global  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030 (US$ Mn)
19. North America  Pharmacovigilance Market Analysis
19.1. Overview
19.1.1. Market Dynamics for North America
19.1.1.1. Drivers
19.1.1.2. Restraints
19.1.1.3. Opportunities
19.1.1.4. Trends
19.2. North America  Pharmacovigilance Market, By Service Type, 2017-2030(US$ Mn)
19.2.1. Overview
19.2.2. SRC Analysis
19.3. North America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030(US$ Mn)
19.3.1. Overview
19.3.2. SRC Analysis
19.4. North America  Pharmacovigilance Market, By End-User, 2017-2030(US$ Mn)
19.4.1. Overview
19.4.2. SRC Analysis
19.5. North America  Pharmacovigilance Market, By Type of Reporting, 2017-2030(US$ Mn)
19.5.1. Overview
19.5.2. SRC Analysis
19.6. North America  Pharmacovigilance Market, By Data Sources, 2017-2030(US$ Mn)
19.6.1. Overview
19.6.2. SRC Analysis
19.7. North America  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030(US$ Mn)
19.7.1. Overview
19.7.2. SRC Analysis
19.8. North America  Pharmacovigilance Market, By Type of Service Providers, 2017-2030(US$ Mn)
19.8.1. Overview
19.8.2. SRC Analysis
19.9. North America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030(US$ Mn)
19.9.1. Overview
19.9.2. SRC Analysis
19.10. North America  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030(US$ Mn)
19.10.1. Overview
19.10.2. SRC Analysis
19.11. North America  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030(US$ Mn)
19.11.1. Overview
19.11.2. SRC Analysis
19.12. North America  Pharmacovigilance Market, by Country, 2017-2030(US$ Mn)
19.12.1. North America  Pharmacovigilance Market, by Country, 2022 Vs 2030 (in%)
19.12.2. U.S.
19.12.3. Canada
19.12.4. Mexico
20. Europe  Pharmacovigilance Market Analysis
20.1. Overview
20.1.1. Market Dynamics for North America
20.1.1.1. Drivers
20.1.1.2. Restraints
20.1.1.3. Opportunities
20.1.1.4. Trends
20.2. Europe  Pharmacovigilance Market, By Service Type, 2017-2030(US$ Mn)
20.2.1. Overview
20.2.2. SRC Analysis
20.3. Europe  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030(US$ Mn)
20.3.1. Overview
20.3.2. SRC Analysis
20.4. Europe  Pharmacovigilance Market, By End-User, 2017-2030(US$ Mn)
20.4.1. Overview
20.4.2. SRC Analysis
20.5. Europe  Pharmacovigilance Market, By Type of Reporting, 2017-2030(US$ Mn)
20.5.1. Overview
20.5.2. SRC Analysis
20.6. Europe  Pharmacovigilance Market, By Data Sources, 2017-2030(US$ Mn)
20.6.1. Overview
20.6.2. SRC Analysis
20.7. Europe  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030(US$ Mn)
20.7.1. Overview
20.7.2. SRC Analysis
20.8. Europe  Pharmacovigilance Market, By Type of Service Providers, 2017-2030(US$ Mn)
20.8.1. Overview
20.8.2. SRC Analysis
20.9. Europe  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030(US$ Mn)
20.9.1. Overview
20.9.2. SRC Analysis
20.10. Europe  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030(US$ Mn)
20.10.1. Overview
20.10.2. SRC Analysis
20.11. Europe  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030(US$ Mn)
20.11.1. Overview
20.11.2. SRC Analysis
20.12. Europe  Pharmacovigilance Market, by Country, 2017-2030 (US$ Mn)
20.12.1. Europe  Pharmacovigilance Market, by Country, 2022 Vs 2030 (in%)
20.12.2. UK
20.12.3. France
20.12.4. Germany
20.12.5. Italy
20.12.6. Spain
20.12.7. Benelux
20.12.8. Russia
20.12.9. Rest of Europe
21. Asia Pacific  Pharmacovigilance Market Analysis
21.1. Overview
21.1.1. Market Dynamics for North America
21.1.1.1. Drivers
21.1.1.2. Restraints
21.1.1.3. Opportunities
21.1.1.4. Trends
21.2. Asia Pacific  Pharmacovigilance Market, By Service Type, 2017-2030(US$ Mn)
21.2.1. Overview
21.2.2. SRC Analysis
21.3. Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030(US$ Mn)
21.3.1. Overview
21.3.2. SRC Analysis
21.4. Asia Pacific  Pharmacovigilance Market, By End-User, 2017-2030(US$ Mn)
21.4.1. Overview
21.4.2. SRC Analysis
21.5. Asia Pacific  Pharmacovigilance Market, By Type of Reporting, 2017-2030(US$ Mn)
21.5.1. Overview
21.5.2. SRC Analysis
21.6. Asia Pacific  Pharmacovigilance Market, By Data Sources, 2017-2030(US$ Mn)
21.6.1. Overview
21.6.2. SRC Analysis
21.7. Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030(US$ Mn)
21.7.1. Overview
21.7.2. SRC Analysis
21.8. Asia Pacific  Pharmacovigilance Market, By Type of Service Providers, 2017-2030(US$ Mn)
21.8.1. Overview
21.8.2. SRC Analysis
21.9. Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030(US$ Mn)
21.9.1. Overview
21.9.2. SRC Analysis
21.10. Asia Pacific  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030(US$ Mn)
21.10.1. Overview
21.10.2. SRC Analysis
21.11. Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030(US$ Mn)
21.11.1. Overview
21.11.2. SRC Analysis
21.12. Asia Pacific  Pharmacovigilance Market, by Country, 2017-2030 (US$ Mn)
21.12.1. Asia Pacific  Pharmacovigilance Market, by Country, 2022 Vs 2030 (in%)
21.12.2. China
21.12.3. Japan
21.12.4. India
21.12.5. South Korea
21.12.6. South East Asia
21.12.7. Rest of Asia Pacific
22. Latin America  Pharmacovigilance Market Analysis
22.1. Overview
22.1.1. Market Dynamics for North America
22.1.1.1. Drivers
22.1.1.2. Restraints
22.1.1.3. Opportunities
22.1.1.4. Trends
22.2. Latin America  Pharmacovigilance Market, By Service Type, 2017-2030(US$ Mn)
22.2.1. Overview
22.2.2. SRC Analysis
22.3. Latin America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030(US$ Mn)
22.3.1. Overview
22.3.2. SRC Analysis
22.4. Latin America  Pharmacovigilance Market, By End-User, 2017-2030(US$ Mn)
22.4.1. Overview
22.4.2. SRC Analysis
22.5. Latin America  Pharmacovigilance Market, By Type of Reporting, 2017-2030(US$ Mn)
22.5.1. Overview
22.5.2. SRC Analysis
22.6. Latin America  Pharmacovigilance Market, By Data Sources, 2017-2030(US$ Mn)
22.6.1. Overview
22.6.2. SRC Analysis
22.7. Latin America  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030(US$ Mn)
22.7.1. Overview
22.7.2. SRC Analysis
22.8. Latin America  Pharmacovigilance Market, By Type of Service Providers, 2017-2030(US$ Mn)
22.8.1. Overview
22.8.2. SRC Analysis
22.9. Latin America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030(US$ Mn)
22.9.1. Overview
22.9.2. SRC Analysis
22.10. Latin America  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030(US$ Mn)
22.10.1. Overview
22.10.2. SRC Analysis
22.11. Latin America  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030(US$ Mn)
22.11.1. Overview
22.11.2. SRC Analysis
22.12. Latin America  Pharmacovigilance Market, by Country, 2017-2030 (US$ Mn)
22.12.1. Latin America  Pharmacovigilance Market, by Country, 2022 Vs 2030 (in%)
22.12.2. Brazil
22.12.3. Argentina
22.12.4. Rest of Latin America
23. Middle East  Pharmacovigilance Market Analysis
23.1. Overview
23.1.1. Market Dynamics for North America
23.1.1.1. Drivers
23.1.1.2. Restraints
23.1.1.3. Opportunities
23.1.1.4. Trends
23.2. Middle East  Pharmacovigilance Market, By Service Type, 2017-2030(US$ Mn)
23.2.1. Overview
23.2.2. SRC Analysis
23.3. Middle East  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030(US$ Mn)
23.3.1. Overview
23.3.2. SRC Analysis
23.4. Middle East  Pharmacovigilance Market, By End-User, 2017-2030(US$ Mn)
23.4.1. Overview
23.4.2. SRC Analysis
23.5. Middle East  Pharmacovigilance Market, By Type of Reporting, 2017-2030(US$ Mn)
23.5.1. Overview
23.5.2. SRC Analysis
23.6. Middle East  Pharmacovigilance Market, By Data Sources, 2017-2030(US$ Mn)
23.6.1. Overview
23.6.2. SRC Analysis
23.7. Middle East  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030(US$ Mn)
23.7.1. Overview
23.7.2. SRC Analysis
23.8. Middle East  Pharmacovigilance Market, By Type of Service Providers, 2017-2030(US$ Mn)
23.8.1. Overview
23.8.2. SRC Analysis
23.9. Middle East  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030(US$ Mn)
23.9.1. Overview
23.9.2. SRC Analysis
23.10. Middle East  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030(US$ Mn)
23.10.1. Overview
23.10.2. SRC Analysis
23.11. Middle East  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030(US$ Mn)
23.11.1. Overview
23.11.2. SRC Analysis
23.12. Middle East  Pharmacovigilance Market, by Country, 2017-2030 (US$ Mn)
23.12.1. Middle East  Pharmacovigilance Market, by Country, 2022 Vs 2030 (in%)
23.12.2. UAE
23.12.3. Saudi Arabia
23.12.4. Rest of Middle East
24. Africa  Pharmacovigilance Market Analysis
24.1. Overview
24.1.1. Market Dynamics for North America
24.1.1.1. Drivers
24.1.1.2. Restraints
24.1.1.3. Opportunities
24.1.1.4. Trends
24.2. Africa  Pharmacovigilance Market, By Service Type, 2017-2030(US$ Mn)
24.2.1. Overview
24.2.2. SRC Analysis
24.3. Africa  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2030(US$ Mn)
24.3.1. Overview
24.3.2. SRC Analysis
24.4. Africa  Pharmacovigilance Market, By End-User, 2017-2030(US$ Mn)
24.4.1. Overview
24.4.2. SRC Analysis
24.5. Africa  Pharmacovigilance Market, By Type of Reporting, 2017-2030(US$ Mn)
24.5.1. Overview
24.5.2. SRC Analysis
24.6. Africa  Pharmacovigilance Market, By Data Sources, 2017-2030(US$ Mn)
24.6.1. Overview
24.6.2. SRC Analysis
24.7. Africa  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2030(US$ Mn)
24.7.1. Overview
24.7.2. SRC Analysis
24.8. Africa  Pharmacovigilance Market, By Type of Service Providers, 2017-2030(US$ Mn)
24.8.1. Overview
24.8.2. SRC Analysis
24.9. Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2030(US$ Mn)
24.9.1. Overview
24.9.2. SRC Analysis
24.10. Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, 2017-2030(US$ Mn)
24.10.1. Overview
24.10.2. SRC Analysis
24.11. Africa  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2030(US$ Mn)
24.11.1. Overview
24.11.2. SRC Analysis
24.12. Africa  Pharmacovigilance Market, by Country, 2017-2030 (US$ Mn)
24.12.1. Middle East  Pharmacovigilance Market, by Country, 2022 Vs 2030 (in%)
24.12.2. South Africa
24.12.3. Egypt
24.12.4. Rest of Africa
25. Company Profiles
25.1. Accenture
25.1.1. Company Overview
25.1.2. Types/Services Portfolio
25.1.3. Geographical Presence
25.1.4. SWOT Analysis
25.1.5. Financial Summary
25.1.5.1. Market Revenue and Net Profit (2019-2022)
25.1.5.2. Business Segment Revenue Analysis
25.1.5.3. Geographical Revenue Analysis
25.2. IQVIA
25.3. Cognizant
25.4. Clinquest Group B.V. (Linical Americas)
25.5. IBM Corp.
25.6. Laboratory Corporation of America Holdings
25.7. ArisGlobal
25.8. Capgemini
25.9. ITClinical
25.10. ICON plc.
25.11. TAKE Solutions Ltd.
25.12. Parexel International Corporation.
25.13. Wipro Ltd.
25.14. United BioSource LLC
25.15. BioClinica Inc.
25.16. ClinChoice (formerly FMD K&L)
26. Research Methodology
26.1. Research Methodology
26.2. Pharmaceutical Companies – Secondary Research
26.3. Pharmaceutical CompaniesI – Data Modelling
26.3.1. Company Share Analysis Model
26.3.2. Revenue Based Modelling
26.4. Pharmaceutical CompaniesII – Primary Research
26.5. Research Limitations
26.5.1. Assumptions
List of Figures
FIG. 1 Global  Pharmacovigilance Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global  Pharmacovigilance Market Segmentation
FIG. 4 Global  Pharmacovigilance Market, By Service Type, 2022 (US$ Mn)
FIG. 5 Global  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2022 (US$ Mn)
FIG. 6 Global  Pharmacovigilance Market, By End-User, 2022 (US$ Mn)
FIG. 7 Global  Pharmacovigilance Market, by Type of Reporting, 2022 (US$ Mn)
FIG. 8 Global  Pharmacovigilance Market, By Data Sources, 2022 (US$ Mn)
FIG. 9 Global  Pharmacovigilance Market, By  Pharmacovigilance Software, 2022 (US$ Mn)
FIG. 10 Global  Pharmacovigilance Market, By Type of Service Providers, 2022 (US$ Mn)
FIG. 11 Global  Pharmacovigilance Market, By  Pharmacovigilance Center, 2022 (US$ Mn)
FIG. 12 Global  Pharmacovigilance Market, by Regulatory Reporting Requirements, 2022 (US$ Mn)
FIG. 13 Global  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2022 (US$ Mn)
FIG. 14 Global  Pharmacovigilance Market, by Geography, 2022 (US$ Mn)
FIG. 15 Attractive Investment Proposition, By Service Type, 2022
FIG. 16 Attractive Investment Proposition, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2022
FIG. 17 Attractive Investment Proposition, By End-User, 2022
FIG. 18 Attractive Investment Proposition, By Type of Reporting, 2022
FIG. 19 Attractive Investment Proposition, By Data Sources, 2022
FIG. 20 Attractive Investment Proposition, By  Pharmacovigilance Software, 2022
FIG. 21 Attractive Investment Proposition, By Type of Service Providers, 2022
FIG. 22 Attractive Investment Proposition, By  Pharmacovigilance Center, 2022
FIG. 23 Attractive Investment Proposition, By Regulatory Reporting Requirements, 2022
FIG. 24 Attractive Investment Proposition, By  Pharmacovigilance Audits and Inspections, 2022
FIG. 25 Attractive Investment Proposition, by Geography, 2022
FIG. 26 Global Market Share Analysis of Key  Pharmacovigilance Market Manufacturers, 2022
FIG. 27 Global Market Positioning of Key  Pharmacovigilance Market Manufacturers, 2022
FIG. 28 Global  Pharmacovigilance Market Value Contribution, By Service Type, 2022 & 2030 (Value %)
FIG. 29 Global  Pharmacovigilance Market, by IN-HOUSE  Pharmacovigilance SERVICES, Value, 2017-2030 (US$ Mn)
FIG. 30 Global  Pharmacovigilance Market, by Outsourced  Pharmacovigilance Services, Value, 2017-2030 (US$ Mn)
FIG. 31 Global  Pharmacovigilance Market Value Contribution, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2022 & 2030 (Value %)
FIG. 32 Global  Pharmacovigilance Market, by Case Processing, Value, 2017-2030 (US$ Mn)
FIG. 33 Global  Pharmacovigilance Market, by Signal Detection, Value, 2017-2030 (US$ Mn)
FIG. 34 Global  Pharmacovigilance Market, by Risk Management Services, Value, 2017-2030 (US$ Mn)
FIG. 35 Global  Pharmacovigilance Market, by Regulatory Affairs Outsourcing, Value, 2017-2030 (US$ Mn)
FIG. 36 Global  Pharmacovigilance Market Value Contribution, By End-User, 2022 & 2030 (Value %)
FIG. 37 Global  Pharmacovigilance Market, by Pharmaceutical Companies, Value, 2017-2030 (US$ Mn)
FIG. 38 Global  Pharmacovigilance Market, by Biotechnology Companies, Value, 2017-2030 (US$ Mn)
FIG. 39 Global  Pharmacovigilance Market, by Contract Research Organizations (CROs), Value, 2017-2030 (US$ Mn)
FIG. 40 Global  Pharmacovigilance Market, by Medical Device Companies, Value, 2017-2030 (US$ Mn)
FIG. 41 Global  Pharmacovigilance Market, by Academic Research Institutes, Value, 2017-2030 (US$ Mn)
FIG. 42 Global  Pharmacovigilance Market Value Contribution, By Type of Reporting, 2022 & 2030 (Value %)
FIG. 43 Global  Pharmacovigilance Market, by Spontaneous Reporting, Value, 2017-2030 (US$ Mn)
FIG. 44 Global  Pharmacovigilance Market, by Intensified ADR Reporting, Value, 2017-2030 (US$ Mn)
FIG. 45 Global  Pharmacovigilance Market, by Targeted Spontaneous Reporting, Value, 2017-2030 (US$ Mn)
FIG. 46 Global  Pharmacovigilance Market, by Cohort Event Monitoring, Value, 2017-2030 (US$ Mn)
FIG. 47 Global  Pharmacovigilance Market Value Contribution, By Data Sources, 2022 & 2030 (Value %)
FIG. 48 Global  Pharmacovigilance Market, by Clinical Trials Data, Value, 2017-2030 (US$ Mn)
FIG. 49 Global  Pharmacovigilance Market, by Post-Marketing Surveillance Data, Value, 2017-2030 (US$ Mn)
FIG. 50 Global  Pharmacovigilance Market, by Patient Support Programs, Value, 2017-2030 (US$ Mn)
FIG. 51 Global  Pharmacovigilance Market, by Social Media and Patient Forums, Value, 2017-2030 (US$ Mn)
FIG. 52 Global  Pharmacovigilance Market, by Medical Literature, Value, 2017-2030 (US$ Mn)
FIG. 53 Global  Pharmacovigilance Market Value Contribution, By  Pharmacovigilance Software, 2022 & 2030 (Value %)
FIG. 54 Global  Pharmacovigilance Market, by Adverse Event Reporting Software, Value, 2017-2030 (US$ Mn)
FIG. 55 Global  Pharmacovigilance Market, by Signal Detection Software, Value, 2017-2030 (US$ Mn)
FIG. 56 Global  Pharmacovigilance Market, by Risk Management Software, Value, 2017-2030 (US$ Mn)
FIG. 57 Global  Pharmacovigilance Market, by Integrated Software Solutions, Value, 2017-2030 (US$ Mn)
FIG. 58 Global  Pharmacovigilance Market Value Contribution, By Type of Service Providers, 2022 & 2030 (Value %)
FIG. 59 Global  Pharmacovigilance Market, by Business Process Outsourcing (BPO) Companies, Value, 2017-2030 (US$ Mn)
FIG. 60 Global  Pharmacovigilance Market, by Contract Research Organizations (CROs), Value, 2017-2030 (US$ Mn)
FIG. 61 Global  Pharmacovigilance Market, by  Pharmacovigilance Service Providers, Value, 2017-2030 (US$ Mn)
FIG. 62 Global  Pharmacovigilance Market Value Contribution, By  Pharmacovigilance Center, 2022 & 2030 (Value %)
FIG. 63 Global  Pharmacovigilance Market, by National  Pharmacovigilance Centers, Value, 2017-2030 (US$ Mn)
FIG. 64 Global  Pharmacovigilance Market, by Regional  Pharmacovigilance Centers, Value, 2017-2030 (US$ Mn)
FIG. 65 Global  Pharmacovigilance Market, by Global  Pharmacovigilance Centers, Value, 2017-2030 (US$ Mn)
FIG. 66 Global  Pharmacovigilance Market Value Contribution, By Regulatory Reporting Requirements, 2022 & 2030 (Value %)
FIG. 67 Global  Pharmacovigilance Market, by FDA (U.S. Food and Drug Administration) Reporting, Value, 2017-2030 (US$ Mn)
FIG. 68 Global  Pharmacovigilance Market, by EMA (European Medicines Agency) Reporting, Value, 2017-2030 (US$ Mn)
FIG. 69 Global  Pharmacovigilance Market, by Other Regional Health Authorities, Value, 2017-2030 (US$ Mn)
FIG. 70 Global  Pharmacovigilance Market Value Contribution, By  Pharmacovigilance Audits and Inspections, 2022 & 2030 (Value %)
FIG. 71 Global  Pharmacovigilance Market, by Internal Auditss, Value, 2017-2030 (US$ Mn)
FIG. 72 Global  Pharmacovigilance Market, by External Audits, Value, 2017-2030 (US$ Mn)
FIG. 73 Global  Pharmacovigilance Market, by Regulatory Inspections, Value, 2017-2030 (US$ Mn)
FIG. 74 North America  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 75 U.S.  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 76 Canada  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 77 Mexico Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 78 Europe  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 79 Germany  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 80 France  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 81 U.K.  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 82 Italy  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 83 Spain  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 84 Benelux Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 85 Russia Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 86 Rest of Europe  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 87 Asia Pacific  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 88 China  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 89 Japan  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 90 India  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 91 South Korea  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 92 South-East Asia  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 93 Rest of Asia Pacific  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 94 Latin America  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 95 Brazil  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 96 Argentina Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 97 Rest of Latin America  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 98 Middle East  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 99 UAE Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 100 Saudi Arabia Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 101 Rest of Middle East  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 102 Africa Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 103 South Africa  Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 104 Egypt Pharmacovigilance Market, 2017-2030 (US$ Mn)
FIG. 105 Rest of Africa  Pharmacovigilance Market, 2017-2030 (US$ Mn)
List of Tables
TABLE 1 Market Snapshot: Global  Pharmacovigilance Market
TABLE 2 Global  Pharmacovigilance Market: Drivers Impact Analysis
TABLE 3 Global  Pharmacovigilance Market: Market Restraints Impact Analysis
TABLE 4 Global  Pharmacovigilance Market, by Competitive Benchmarking, 2022
TABLE 5 Global  Pharmacovigilance Market, by Geographical Presence Analysis, 2022
TABLE 6 Global  Pharmacovigilance Market, by Key Strategies Analysis, 2022
TABLE 7 Global  Pharmacovigilance Market, by In-House  Pharmacovigilance Services, By Region, 2017-2022 (US$ Mn)
TABLE 8 Global  Pharmacovigilance Market, by In-House  Pharmacovigilance Services, By Region, 2023-2030 (US$ Mn)
TABLE 9 Global  Pharmacovigilance Market, by Outsourced  Pharmacovigilance Services, By Region, 2017-2022 (US$ Mn)
TABLE 10 Global  Pharmacovigilance Market, by Outsourced  Pharmacovigilance Services, By Region, 2023-2030 (US$ Mn)
TABLE 11 Global  Pharmacovigilance Market, by Case Processing, By Region, 2017-2022 (US$ Mn)
TABLE 12 Global  Pharmacovigilance Market, by Case Processing, By Region, 2023-2030 (US$ Mn)
TABLE 13 Global  Pharmacovigilance Market, by Signal Detection, By Region, 2017-2022 (US$ Mn)
TABLE 14 Global  Pharmacovigilance Market, by Signal Detection, By Region, 2023-2030 (US$ Mn)
TABLE 15 Global  Pharmacovigilance Market, by Risk Management Services, By Region, 2017-2022 (US$ Mn)
TABLE 16 Global  Pharmacovigilance Market, by Risk Management Services, By Region, 2023-2030 (US$ Mn)
TABLE 17 Global  Pharmacovigilance Market, by Regulatory Affairs Outsourcing, By Region, 2017-2022 (US$ Mn)
TABLE 18 Global  Pharmacovigilance Market, by Regulatory Affairs Outsourcing, By Region, 2023-2030 (US$ Mn)
TABLE 19 Global  Pharmacovigilance Market, by Pharmaceutical Companies, By Region, 2017-2022 (US$ Mn)
TABLE 20 Global  Pharmacovigilance Market, by Pharmaceutical Companies, By Region, 2023-2030 (US$ Mn)
TABLE 21 Global  Pharmacovigilance Market, by Biotechnology Companies, By Region, 2017-2022 (US$ Mn)
TABLE 22 Global  Pharmacovigilance Market, by Biotechnology Companies, By Region, 2023-2030 (US$ Mn)
TABLE 23 Global  Pharmacovigilance Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 24 Global  Pharmacovigilance Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 25 Global  Pharmacovigilance Market, by Medical Device Companies, By Region, 2017-2022 (US$ Mn)
TABLE 26 Global  Pharmacovigilance Market, by Medical Device Companies, By Region, 2023-2030 (US$ Mn)
TABLE 27 Global  Pharmacovigilance Market, by Academic Research Institutes, By Region, 2017-2022 (US$ Mn)
TABLE 28 Global  Pharmacovigilance Market, by Academic Research Institutes, By Region, 2023-2030 (US$ Mn)
TABLE 29 Global  Pharmacovigilance Market, by Spontaneous Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 30 Global  Pharmacovigilance Market, by Spontaneous Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 31 Global  Pharmacovigilance Market, by Intensified ADR Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 32 Global  Pharmacovigilance Market, by Intensified ADR Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 33 Global  Pharmacovigilance Market, by Targeted Spontaneous Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 34 Global  Pharmacovigilance Market, by Targeted Spontaneous Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 35 Global  Pharmacovigilance Market, by Cohort Event Monitoring, By Region, 2017-2022 (US$ Mn)
TABLE 36 Global  Pharmacovigilance Market, by Cohort Event Monitoring, By Region, 2023-2030 (US$ Mn)
TABLE 37 Global  Pharmacovigilance Market, by Clinical Trials Data, By Region, 2017-2022 (US$ Mn)
TABLE 38 Global  Pharmacovigilance Market, by Clinical Trials Data, By Region, 2023-2030 (US$ Mn)
TABLE 39 Global  Pharmacovigilance Market, by Post-Marketing Surveillance Data, By Region, 2017-2022 (US$ Mn)
TABLE 40 Global  Pharmacovigilance Market, by Post-Marketing Surveillance Data, By Region, 2023-2030 (US$ Mn)
TABLE 41 Global  Pharmacovigilance Market, by Patient Support Programs, By Region, 2017-2022 (US$ Mn)
TABLE 42 Global  Pharmacovigilance Market, by Patient Support Programs, By Region, 2023-2030 (US$ Mn)
TABLE 43 Global  Pharmacovigilance Market, by Social Media and Patient Forums, By Region, 2017-2022 (US$ Mn)
TABLE 44 Global  Pharmacovigilance Market, by Social Media and Patient Forums, By Region, 2023-2030 (US$ Mn)
TABLE 45 Global  Pharmacovigilance Market, by Medical Literature, By Region, 2017-2022 (US$ Mn)
TABLE 46 Global  Pharmacovigilance Market, by Medical Literature, By Region, 2023-2030 (US$ Mn)
TABLE 47 Global  Pharmacovigilance Market, by Adverse Event Reporting Software, By Region, 2017-2022 (US$ Mn)
TABLE 48 Global  Pharmacovigilance Market, by Adverse Event Reporting Software, By Region, 2023-2030 (US$ Mn)
TABLE 49 Global  Pharmacovigilance Market, by Signal Detection Software, By Region, 2017-2022 (US$ Mn)
TABLE 50 Global  Pharmacovigilance Market, by Signal Detection Software, By Region, 2023-2030 (US$ Mn)
TABLE 51 Global  Pharmacovigilance Market, by Risk Management Software, By Region, 2017-2022 (US$ Mn)
TABLE 52 Global  Pharmacovigilance Market, by Risk Management Software, By Region, 2023-2030 (US$ Mn)
TABLE 53 Global  Pharmacovigilance Market, by Integrated Software Solutions, By Region, 2017-2022 (US$ Mn)
TABLE 54 Global  Pharmacovigilance Market, by Integrated Software Solutions, By Region, 2023-2030 (US$ Mn)
TABLE 55 Global  Pharmacovigilance Market, by Business Process Outsourcing (BPO) Companies, By Region, 2017-2022 (US$ Mn)
TABLE 56 Global  Pharmacovigilance Market, by Business Process Outsourcing (BPO) Companies, By Region, 2023-2030 (US$ Mn)
TABLE 57 Global  Pharmacovigilance Market, by Contract Research Organizations (CROs), By Region, 2017-2022 (US$ Mn)
TABLE 58 Global  Pharmacovigilance Market, by Contract Research Organizations (CROs), By Region, 2023-2030 (US$ Mn)
TABLE 59 Global  Pharmacovigilance Market, by  Pharmacovigilance Service Providers, By Region, 2017-2022 (US$ Mn)
TABLE 60 Global  Pharmacovigilance Market, by  Pharmacovigilance Service Providers, By Region, 2023-2030 (US$ Mn)
TABLE 61 Global  Pharmacovigilance Market, by National  Pharmacovigilance Centers, By Region, 2017-2022 (US$ Mn)
TABLE 62 Global  Pharmacovigilance Market, by National  Pharmacovigilance Centers, By Region, 2023-2030 (US$ Mn)
TABLE 63 Global  Pharmacovigilance Market, by Regional  Pharmacovigilance Centers, By Region, 2017-2022 (US$ Mn)
TABLE 64 Global  Pharmacovigilance Market, by Regional  Pharmacovigilance Centers, By Region, 2023-2030 (US$ Mn)
TABLE 65 Global  Pharmacovigilance Market, by Global  Pharmacovigilance Centers, By Region, 2017-2022 (US$ Mn)
TABLE 66 Global  Pharmacovigilance Market, by Global  Pharmacovigilance Centers, By Region, 2023-2030 (US$ Mn)
TABLE 67 Global  Pharmacovigilance Market, by FDA (U.S. Food and Drug Administration) Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 68 Global  Pharmacovigilance Market, by FDA (U.S. Food and Drug Administration) Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 69 Global  Pharmacovigilance Market, by EMA (European Medicines Agency) Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 70 Global  Pharmacovigilance Market, by EMA (European Medicines Agency) Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 71 Global  Pharmacovigilance Market, by Other Regional Health Authorities, By Region, 2017-2022 (US$ Mn)
TABLE 72 Global  Pharmacovigilance Market, by Other Regional Health Authorities, By Region, 2023-2030 (US$ Mn)
TABLE 73 Global  Pharmacovigilance Market, by Internal Auditss, By Region, 2017-2022 (US$ Mn)
TABLE 74 Global  Pharmacovigilance Market, by Internal Auditss, By Region, 2023-2030 (US$ Mn)
TABLE 75 Global  Pharmacovigilance Market, by External Audits, By Region, 2017-2022 (US$ Mn)
TABLE 76 Global  Pharmacovigilance Market, by External Audits, By Region, 2023-2030 (US$ Mn)
TABLE 77 Global  Pharmacovigilance Market, by Regulatory Inspections, By Region, 2017-2022 (US$ Mn)
TABLE 78 Global  Pharmacovigilance Market, by Regulatory Inspections, By Region, 2023-2030 (US$ Mn)
TABLE 79 Global  Pharmacovigilance Market, by Compliance with Regulatory Standards, By Region, 2017-2022 (US$ Mn)
TABLE 80 Global  Pharmacovigilance Market, by Compliance with Regulatory Standards, By Region, 2023-2030 (US$ Mn)
TABLE 81 Global  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 82 Global  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 83 Global  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 84 Global  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 85 Global  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 86 Global  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 87 Global  Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 88 Global  Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 89 Global  Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 90 Global  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 91 Global  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 92 Global  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 93 Global  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 94 Global  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 95 Global  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 96 Global  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 97 Global  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 98 Global  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 99 Global  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 100 Global  Pharmacovigilance Market, by Region, 2017-2022 (US$ Mn)
TABLE 101 Global  Pharmacovigilance Market, by Region, 2023-2030 (US$ Mn)
TABLE 102 North America  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 103 North America  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 104 North America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 105 North America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 106 North America  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 107 North America  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 108 North America Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 109 North America Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 110 North America Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 111 North America Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 112 North America  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 113 North America  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 114 North America  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 115 North America  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 116 North America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 117 North America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 118 North America Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 119 North America Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 120 North America Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 121 North America Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 122 North America  Pharmacovigilance Market, by Country, 2017-2022 (US$ Mn)
TABLE 123 North America  Pharmacovigilance Market, by Country, 2023-2030 (US$ Mn)
TABLE 124 United States  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 125 United States  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 126 United States  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 127 United States  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 128 United States  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 129 United States  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 130 United States Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 131 United States Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 132 United States Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 133 United States Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 134 United States  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 135 United States  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 136 United States  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 137 United States  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 138 United States  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 139 United States  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 140 United States  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 141 United States  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 142 United States  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 143 United States  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 144 Canada  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 145 Canada  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 146 Canada  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 147 Canada  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 148 Canada  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 149 Canada  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 150 Canada Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 151 Canada Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 152 Canada Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 153 Canada  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 154 Canada  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 155 Canada  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 156 Canada  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 157 Canada  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 158 Canada  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 159 Canada  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 160 Canada  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 161 Canada  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 162 Canada  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 163 Canada  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 164 Mexico  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 165 Mexico  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 166 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 167 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 168 Mexico  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 169 Mexico  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 170 Mexico Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 171 Mexico Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 172 Mexico Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 173 Mexico  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 174 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 175 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 176 Mexico  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 177 Mexico  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 178 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 179 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 180 Mexico  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 181 Mexico  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 182 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 183 Mexico  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 184 Europe  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 185 Europe  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 186 Europe  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 187 Europe  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 188 Europe  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 189 Europe  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 190 Europe Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 191 Europe Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 192 Europe Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 193 Europe Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 194 Europe  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 195 Europe  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 196 Europe  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 197 Europe  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 198 Europe  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 199 Europe  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 200 Europe  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 201 Europe  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 202 Europe  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 203 Europe  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 204 Europe  Pharmacovigilance Market, by Country, 2017-2022 (US$ Mn)
TABLE 205 Europe  Pharmacovigilance Market, by Country, 2023-2030 (US$ Mn)
TABLE 206 Germany  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 207 Germany  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 208 Germany  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 209 Germany  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 210 Germany  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 211 Germany  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 212 Germany Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 213 Germany Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 214 Germany Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 215 Germany  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 216 Germany  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 217 Germany  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 218 Germany  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 219 Germany  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 220 Germany  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 221 Germany  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 222 Germany  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 223 Germany  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 224 Germany  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 225 Germany  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 226 France  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 227 France  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 228 France  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 229 France  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 230 France  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 231 France  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 232 France Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 233 France Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 234 France Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 235 France  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 236 France  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 237 France  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 238 France  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 239 France  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 240 France  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 241 France  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 242 France  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 243 France  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 244 France  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 245 France  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 246 United Kingdom  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 247 United Kingdom  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 248 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 249 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 250 United Kingdom  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 251 United Kingdom  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 252 United Kingdom Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 253 United Kingdom Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 254 United Kingdom Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 255 United Kingdom  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 256 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 257 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 258 United Kingdom  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 259 United Kingdom  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 260 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 261 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 262 United Kingdom  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 263 United Kingdom  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 264 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 265 United Kingdom  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 266 Italy  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 267 Italy  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 268 Italy  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 269 Italy  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 270 Italy  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 271 Italy  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 272 Italy Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 273 Italy Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 274 Italy Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 275 Italy  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 276 Italy  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 277 Italy  Pharmacovigilance Market, By  Pharmacovigilance Software, 2023-2030 (US$ Mn)
TABLE 278 Italy  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 279 Italy  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 280 Italy  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 281 Italy  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 282 Italy  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 283 Italy  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 284 Italy  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 285 Italy  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 286 Spain  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 287 Spain  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 288 Spain  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 289 Spain  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 290 Spain  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 291 Spain  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 292 Spain Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 293 Spain Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 294 Spain Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 295 Spain  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 296 Spain  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 297 Spain  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 298 Spain  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 299 Spain  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 300 Spain  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 301 Spain  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 302 Spain  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 303 Spain  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 304 Spain  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 305 Spain  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 306 Benelux Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 307 Benelux Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 308 Benelux Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 309 Benelux Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 310 Benelux Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 311 Benelux Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 312 Benelux Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 313 Benelux Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 314 Benelux Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 315 Benelux  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 316 Benelux  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 317 Benelux  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 318 Benelux  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 319 Benelux  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 320 Benelux  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 321 Benelux  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 322 Benelux  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 323 Benelux  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 324 Benelux  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 325 Benelux  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 326 Russia Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 327 Russia Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 328 Russia Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 329 Russia Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 330 Russia Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 331 Russia Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 332 Russia Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 333 Russia Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 334 Russia Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 335 Russia  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 336 Russia  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 337 Russia  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 338 Russia  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 339 Russia  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 340 Russia  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 341 Russia  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 342 Russia  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 343 Russia  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 344 Russia  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 345 Russia  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 346 Rest of Europe  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 347 Rest of Europe  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 348 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 349 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 350 Rest of Europe  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 351 Rest of Europe  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 352 Rest of Europe Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 353 Rest of Europe Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 354 Rest of Europe Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 355 Rest of Europe  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 356 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 357 Rest of Europe  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 358 Rest of Europe  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 359 Rest of Europe  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 360 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 361 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 362 Rest of Europe  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 363 Rest of Europe  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 364 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 365 Rest of Europe  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 366 Asia Pacific  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 367 Asia Pacific  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 368 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 369 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 370 Asia Pacific  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 371 Asia Pacific  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 372 Asia Pacific Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 373 Asia Pacific Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 374 Asia Pacific Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 375 Asia Pacific  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 376 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 377 Asia Pacific  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 378 Asia Pacific  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 379 Asia Pacific  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 380 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 381 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 382 Asia Pacific  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 383 Asia Pacific  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 384 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 385 Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 386 China  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 387 China  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 388 China  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 389 China  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 390 China  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 391 China  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 392 China Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 393 China Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 394 China Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 395 China  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 396 China  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 397 China  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 398 China  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 399 China  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 400 China  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 401 China  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 402 China  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 403 China  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 404 China  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 405 China  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 406 Japan  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 407 Japan  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 408 Japan  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 409 Japan  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 410 Japan  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 411 Japan  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 412 Japan Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 413 Japan Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 414 Japan Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 415 Japan  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 416 Japan  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 417 Japan  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 418 Japan  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 419 Japan  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 420 Japan  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 421 Japan  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 422 Japan  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 423 Japan  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 424 Japan  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 425 Japan  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 426 India  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 427 India  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 428 India  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 429 India  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 430 India  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 431 India  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 432 India Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 433 India Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 434 India Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 435 India  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 436 India  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 437 India  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 438 India  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 439 India  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 440 India  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 441 India  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 442 India  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 443 India  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 444 India  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 445 India  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 446 South Korea  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 447 South Korea  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 448 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 449 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 450 South Korea  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 451 South Korea  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 452 South Korea Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 453 South Korea Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 454 South Korea Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 455 South Korea  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 456 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 457 South Korea  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 458 South Korea  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 459 South Korea  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 460 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 461 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 462 South Korea  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 463 South Korea  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 464 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 465 South Korea  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 466 South-East Asia  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 467 South-East Asia  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 468 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 469 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 470 South-East Asia  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 471 South-East Asia  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 472 South-East Asia Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 473 South-East Asia Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 474 South-East Asia Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 475 South-East Asia  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 476 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 477 South-East Asia  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 478 South-East Asia  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 479 South-East Asia  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 480 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 481 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 482 South-East Asia  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 483 South-East Asia  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 484 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 485 South-East Asia  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 486 Rest of Asia Pacific  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 487 Rest of Asia Pacific  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 488 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 489 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 490 Rest of Asia Pacific  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 491 Rest of Asia Pacific  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 492 Rest of Asia Pacific Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 493 Rest of Asia Pacific Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 494 Rest of Asia Pacific  Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 495 Rest of Asia Pacific Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 496 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 497 Rest of Asia Pacific  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 498 Rest of Asia Pacific  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 499 Rest of Asia Pacific  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 500 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 501 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 502 Rest of Asia Pacific  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 503 Rest of Asia Pacific  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 504 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 505 Rest of Asia Pacific  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 506 Latin America  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 507 Latin America  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 508 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 509 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 510 Latin America  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 511 Latin America  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 512 Latin America Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 513 Latin America Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 514 Latin America Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 515 Latin America  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 516 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 517 Latin America  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 518 Latin America  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 519 Latin America  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 520 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 521 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 522 Latin America  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 523 Latin America  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 524 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 525 Latin America  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 526 Brazil  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 527 Brazil  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 528 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 529 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 530 Brazil  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 531 Brazil  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 532 Brazil Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 533 Brazil Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 534 Brazil Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 535 Brazil  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 536 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 537 Brazil  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 538 Brazil  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 539 Brazil  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 540 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 541 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 542 Brazil  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 543 Brazil  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 544 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 545 Brazil  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 546 Argentina  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 547 Argentina  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 548 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 549 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 550 Argentina  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 551 Argentina  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 552 Argentina Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 553 Argentina Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 554 Argentina Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 555 Argentina  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 556 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 557 Argentina  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 558 Argentina  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 559 Argentina  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 560 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 561 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 562 Argentina  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 563 Argentina  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 564 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 565 Argentina  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 566 Rest of Latin America  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 567 Rest of Latin America  Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 568 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 569 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 570 Rest of Latin America  Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 571 Rest of Latin America  Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 572 Rest of Latin America Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 573 Rest of Latin America Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 574 Rest of Latin America Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 575 Rest of Latin America  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 576 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 577 Rest of Latin America  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 578 Rest of Latin America  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 579 Rest of Latin America  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 580 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 581 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 582 Rest of Latin America  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 583 Rest of Latin America  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 584 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 585 Rest of Latin America  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 586 Middle East Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 587 Middle East Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 588 Middle East Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 589 Middle East Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 590 Middle East Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 591 Middle East Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 592 Middle East Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 593 Middle East Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 594 Middle East Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 595 Middle East  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 596 Middle East  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 597 Middle East  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 598 Middle East  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 599 Middle East  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 600 Middle East  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 601 Middle East  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 602 Middle East  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 603 Middle East  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 604 Middle East  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 605 Middle East  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 606 UAE Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 607 UAE Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 608 UAE Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 609 UAE Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 610 UAE Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 611 UAE Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 612 UAE Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 613 UAE Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 614 UAE Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 615 UAE  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 616 UAE  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 617 UAE  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 618 UAE  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 619 UAE  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 620 UAE  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 621 UAE  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 622 UAE  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 623 UAE  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 624 UAE  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 625 UAE  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 626 Saudi Arabia Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 627 Saudi Arabia Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 628 Saudi Arabia Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 629 Saudi Arabia Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 630 Saudi Arabia Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 631 Saudi Arabia Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 632 Saudi Arabia Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 633 Saudi Arabia Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 634 Saudi Arabia Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 635 Saudi Arabia  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 636 Saudi Arabia  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 637 Saudi Arabia  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 638 Saudi Arabia  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 639 Saudi Arabia  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 640 Saudi Arabia  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 641 Saudi Arabia  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 642 Saudi Arabia  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 643 Saudi Arabia  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 644 Saudi Arabia  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 645 Saudi Arabia  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 646 Rest of Middle East Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 647 Rest of Middle East Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 648 Rest of Middle East Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 649 Rest of Middle East Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 650 Rest of Middle East Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 651 Rest of Middle East Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 652 Rest of Middle East Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 653 Rest of Middle East Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 654 Rest of Middle East Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 655 Rest of Middle East  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 656 Rest of Middle East  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 657 Rest of Middle East  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 658 Rest of Middle East  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 659 Rest of Middle East  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 660 Rest of Middle East  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 661 Rest of Middle East  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 662 Rest of Middle East  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 663 Rest of Middle East  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 664 Rest of Middle East  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 665 Rest of Middle East  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 666 Africa  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 667 Africa Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 668 Africa Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 669 Africa Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 670 Africa Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 671 Africa Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 672 Africa Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 673 Africa Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 674 Africa Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 675 Africa  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 676 Africa  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 677 Africa  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 678 Africa  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 679 Africa  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 680 Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 681 Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 682 Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 683 Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 684 Africa  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 685 Africa  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 686 South Africa  Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 687 South Africa Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 688 South Africa Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 689 South Africa Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 690 South Africa Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 691 South Africa Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 692 South Africa Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 693 South Africa Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 694 South Africa Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 695 South Africa  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 696 South Africa  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 697 South Africa  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 698 South Africa  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 699 South Africa  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 700 South Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 701 South Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 702 South Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 703 South Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 704 South Africa  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 705 South Africa  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 706 Egypt Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 707 Egypt Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 708 Egypt Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 709 Egypt Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 710 Egypt Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 711 Egypt Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 712 Egypt Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 713 Egypt Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 714 Egypt Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 715 Egypt  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 716 Egypt  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 717 Egypt  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 718 Egypt  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 719 Egypt  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 720 Egypt  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 721 Egypt  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 722 Egypt  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 723 Egypt  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 724 Egypt  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
TABLE 725 Egypt  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2023-2030 (US$ Mn)
TABLE 726 Rest of Africa Pharmacovigilance Market, By Service Type, 2017-2022 (US$ Mn)
TABLE 727 Rest of Africa Pharmacovigilance Market, By Service Type, 2023-2030 (US$ Mn)
TABLE 728 Rest of Africa Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2017-2022 (US$ Mn)
TABLE 729 Rest of Africa Pharmacovigilance Market, By  Pharmacovigilance Process Outsourcing (PvPO) Services, 2023-2030 (US$ Mn)
TABLE 730 Rest of Africa Pharmacovigilance Market, By End-User, 2017-2022 (US$ Mn)
TABLE 731 Rest of Africa Pharmacovigilance Market, By End-User, 2023-2030 (US$ Mn)
TABLE 732 Rest of Africa Pharmacovigilance Market, By Type of Reporting, By Region, 2017-2022 (US$ Mn)
TABLE 733 Rest of Africa Pharmacovigilance Market, By Type of Reporting, By Region, 2023-2030 (US$ Mn)
TABLE 734 Rest of Africa Pharmacovigilance Market, By Data Sources, 2017-2022 (US$ Mn)
TABLE 735 Rest of Africa  Pharmacovigilance Market, By Data Sources, 2023-2030 (US$ Mn)
TABLE 736 Rest of Africa  Pharmacovigilance Market, By  Pharmacovigilance Software, 2017-2022 (US$ Mn)
TABLE 737 Rest of Africa  Pharmacovigilance Market, By Clinical Spain Services, 2023-2030 (US$ Mn)
TABLE 738 Rest of Africa  Pharmacovigilance Market, By Type of Service Providers, 2017-2022 (US$ Mn)
TABLE 739 Rest of Africa  Pharmacovigilance Market, By Type of Service Providers, 2023-2030 (US$ Mn)
TABLE 740 Rest of Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2017-2022 (US$ Mn)
TABLE 741 Rest of Africa  Pharmacovigilance Market, By  Pharmacovigilance Center, 2023-2030 (US$ Mn)
TABLE 742 Rest of Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2017-2022 (US$ Mn)
TABLE 743 Rest of Africa  Pharmacovigilance Market, By Regulatory Reporting Requirements, By Region, 2023-2030 (US$ Mn)
TABLE 744 Rest of Africa  Pharmacovigilance Market, By  Pharmacovigilance Audits and Inspections, 2017-2022 (US$ Mn)
What is the current size of the global Pharmacovigilance Market?

The global Pharmacovigilance Market was valued at USD 8615.2 Million in 2023.

What is the expected growth rate of the Pharmacovigilance Market between 2024 and 2032?

The Pharmacovigilance Market is expected to grow at a CAGR of 8.90% between 2024 and 2032, reaching USD 18557.3 Million in 2032.

Which segment is leading the market share in terms of Pharmacovigilance Audits and Inspection?

In 2022, The market’s leading section is regulatory inspections

Which Type of Reporting segment governs the demand for Data Sources?

Post-Marketing Surveillance Data is the category with the most demand.

Which Type of Reporting segment is expected to post the highest CAGR during the forecast period?

The targeted spontaneous reporting sector is predicted to have the quickest CAGR.

Who are the major players in the global Pharmacovigilance Market?

The top players include Accenture; IQVIA; Cognizant; Clinquest Group B.V. (Linical Americas); IBM Corp and Others.

Inulin Market

Published:
Report ID: 11192

Drug Discovery Market

Published:
Report ID: 38270

Neurotrophic Keratitis Treatment Market

Published:
Report ID: 33425

Japan’s Pharmacy Automation Market

Published:
Report ID: 37511

Sterile Active Pharmaceutical Ingredient Market

Published:
Report ID: 37476

Organ Preservation Solutions Market

Published:
Report ID: 37472

Middle East and Africa Veterinary Vaccines Market

Published:
Report ID: 37309

Asia Pacific Stem Cell Therapy Market

Published:
Report ID: 37280

US Active Pharmaceutical Ingredient (API) Market

Published:
Report ID: 37221

Cancer Supportive Care Market

Published:
Report ID: 1901

Middle East and Africa Radiopharmaceuticals Market

Published:
Report ID: 37164

Temperature Controlled Pharma Packaging Solutions Market

Published:
Report ID: 20599

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN